8-K - Vanda Pharmaceuticals Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Vanda Pharmaceuticals Inc. filed an 8-K on 2026-03-10 with Items listed as N/A and an external hint referencing Item 7.01, which shall not be deemed 'filed' under Section 18 of the Exchange Act.

Key Takeaways

1Filing date: 2026-03-10

2Form type: 8-K

3Items: N/A

4External Item Hint: Item 7.01 (not deemed 'filed' under Exchange Act Section 18)

Current Report Details

Event Type

Regulation Fd

Disclosure

Voluntary

Variant

8-K

Items Reported

7.01

shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 (as amended, the “Exchange Act”) or otherwise subject to the l

Regulation Fd

Exhibits (1)

8-K